This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of California. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Robin Knight and His Patent on Microbial Glycosidases
Introduction
Robin Knight is an inventor associated with the University of California in La Jolla, California. His patent work explores how microbial enzymes may help prevent, diagnose, or treat viral infections.
Latest Patents
Knight is associated with 1 patent: “Application of Microbial Glycosidase as an Anti-Viral Therapeutic, Prognostic, and Diagnostic.” The patent describes methods and compositions that use glycosidases or sulfatases to degrade glycans, including heparan sulfate, with the aim of inhibiting viral infection, including COVID-19. It also covers approaches for identifying enzymes or microbes associated with increased susceptibility to viral infection.
Career Highlights
Knight’s listed patent reflects research at the intersection of microbial biology and antiviral innovation. The proposed applications include diagnosing, preventing, and treating viral infections.
Collaborations
Knight’s listed coworkers include Cameron Martino and Jeffrey D. Esko. The patent’s subject matter connects their work to research on microbial enzymes and viral infection.
Conclusion
Robin Knight’s patent highlights a potential enzyme-based approach to addressing viral infections through diagnosis, prevention, and treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile